Dr Thomassen shares his personal experiences with the MFR2 IOL, including reasons why the MFR2 is his lens of preference, clinical findings from a real-life setting and considerations for future use.
Svein Erik Thomassen
Advertisement
Articles by Svein Erik Thomassen
Advertisement
Latest Updated Articles
- Real-world experience with the MFR2 IOL
July 1st 2015
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
2
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
3
Study links alcohol consumption to earlier advanced presbyopia in men
4
The Residency Report: Cardiovascular risk scores as a window into ocular disease
5